Related Experiment Video
Updated: May 9, 2026

12:03
Fertility Preservation in Patients with Severe Ovarian Dysfunction
Published on: March 25, 2021
Acupuncture for Premature Ovarian Insufficiency: A Randomized, Non-Inferiority Protocol with Exploratory Epigenetics
Yu Luo1, Suning Huang1,2, Haichuan Xie3
1Graduate School, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, 510405, People's Republic of China.
International Journal of Women'S Health
|May 8, 2026
Summary
This study compares acupuncture to Hormone Replacement Therapy (HRT) for premature ovarian insufficiency (POI). It investigates if acupuncture is non-inferior to HRT in achieving clinical pregnancy and explores DNA methylation changes.
Area of Science:
- Reproductive Endocrinology
- Integrative Medicine
- Epigenetics
Background:
- Premature ovarian insufficiency (POI) affects women before age 40, impairing fertility.
- Hormone Replacement Therapy (HRT) is standard but has limitations.
- Acupuncture shows promise for POI, but lacks robust evidence and mechanistic understanding.
Purpose of the Study:
- To evaluate if acupuncture is non-inferior to HRT in improving clinical pregnancy rates for women with POI.
- To explore potential epigenetic mechanisms, specifically DNA methylation, underlying POI treatment.
- To provide clinical evidence for acupuncture as an alternative or adjunct therapy for POI.
Main Methods:
- A randomized, controlled, non-inferiority trial involving 572 women with POI undergoing assisted reproductive technology (ART).
- Participants were randomized to receive either acupuncture or HRT.
- Epigenetic analysis included whole-genome bisulfite sequencing (WGBS) on granulosa cells from 286 women.
Main Results:
- The primary outcome is the clinical pregnancy rate.
- Secondary outcomes include hormone levels, ovarian reserve markers, and DNA methylation profiles.
- The study aims to establish non-inferiority of acupuncture versus HRT.
Conclusions:
- This trial will provide crucial data on acupuncture's efficacy for POI.
- Findings may reveal DNA methylation as a key regulatory pathway in POI.
- The study seeks to advance treatment options for women with premature ovarian insufficiency.